Kexing, Chengye Inactivation-Titanium Media Official Website Post date May 17, 2022 — 17:15 Post Lock Read More Green Valley Pharma's Phase 9-1 overseas clinical trial terminated, how difficult is it to develop Alzheimer's disease drugs Post date May 16, 2022 — 21:32 Post Lock Read More [CV Morning Reading] Shanghai will promote the resumption of business and the market in stages from today, and it is rumored that Gome will lay off 40% of its employees – yqqlm Post date May 16, 2022 — 11:25 Post Lock Read More The dawn of the film industry is quiet Post date May 15, 2022 — 08:35 Post Lock Read More What is the salary level of A-share listed companies in 2021? Some companies cut wages by more than 60%, and some reduced their employees by more than 10,000 people Post date May 13, 2022 — 21:15 Post Lock Read More In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000 Post date May 13, 2022 — 15:31 Post Lock Read More In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Green Valley Pharma's Phase 9-1 overseas clinical trial terminated, how difficult is it to develop Alzheimer's disease drugs Post date May 16, 2022 — 21:32 Post Lock Read More [CV Morning Reading] Shanghai will promote the resumption of business and the market in stages from today, and it is rumored that Gome will lay off 40% of its employees – yqqlm Post date May 16, 2022 — 11:25 Post Lock Read More The dawn of the film industry is quiet Post date May 15, 2022 — 08:35 Post Lock Read More What is the salary level of A-share listed companies in 2021? Some companies cut wages by more than 60%, and some reduced their employees by more than 10,000 people Post date May 13, 2022 — 21:15 Post Lock Read More In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000 Post date May 13, 2022 — 15:31 Post Lock Read More In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[CV Morning Reading] Shanghai will promote the resumption of business and the market in stages from today, and it is rumored that Gome will lay off 40% of its employees – yqqlm Post date May 16, 2022 — 11:25 Post Lock Read More The dawn of the film industry is quiet Post date May 15, 2022 — 08:35 Post Lock Read More What is the salary level of A-share listed companies in 2021? Some companies cut wages by more than 60%, and some reduced their employees by more than 10,000 people Post date May 13, 2022 — 21:15 Post Lock Read More In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000 Post date May 13, 2022 — 15:31 Post Lock Read More In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The dawn of the film industry is quiet Post date May 15, 2022 — 08:35 Post Lock Read More What is the salary level of A-share listed companies in 2021? Some companies cut wages by more than 60%, and some reduced their employees by more than 10,000 people Post date May 13, 2022 — 21:15 Post Lock Read More In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000 Post date May 13, 2022 — 15:31 Post Lock Read More In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
What is the salary level of A-share listed companies in 2021? Some companies cut wages by more than 60%, and some reduced their employees by more than 10,000 people Post date May 13, 2022 — 21:15 Post Lock Read More In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000 Post date May 13, 2022 — 15:31 Post Lock Read More In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
In 2021, China Mobile, New Hope and other 14 A-share companies will reduce staff by more than 10,000 Post date May 13, 2022 — 15:31 Post Lock Read More In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
In 2021, 14 A-share companies such as China Mobile and New Hope will reduce their staff by more than 10,000, and companies will cut their wages by more than 60%. Post date May 13, 2022 — 15:29 Post Lock Read More Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Focus on the "new geography" of the capital market丨In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? Post date May 13, 2022 — 10:23 Post Lock Read More In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
In the 2.0 era, can Shenzhen's cross-border e-commerce continue to lead? -Technology Channel-Hexun.com Post date May 13, 2022 — 06:44 Post Lock Read More Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Saudi Aramco replaced Apple as the world's largest market capitalization; SEC added 11 more Chinese concept stocks to pre-delisting Teller Report Post date May 12, 2022 — 13:25 Post Lock Read More The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The last glory of Web2.0, is Douyin really going to be listed this time? _Shenzhen Hotline Post date May 11, 2022 — 11:12 Post Lock Read More Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Weixing has been surveyed by 10 institutions: the company's 2021 annual report has planned the 2022 performance target, and the 2022 performance target is expected to increase by about 15% year-on-year (with survey questions and answers) Post date May 11, 2022 — 11:09 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 9, 2022 — 02:16 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Accused of layoffs before the year-end bonus, Beijing Kexing Zhongwei's net profit in 2021 will exceed 80 billion – yqqlm Post date May 8, 2022 — 16:05 Post Lock Read More Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets Innovative Drugs|Junshi Bio’s new crown drug is in Phase III clinical trial and Pfizer’s Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets Innovative Drugs Junshi Bio’s new crown drug is in Phase III clinical trials with Pfizer’s Paxlovid to conduct head-to-head clinical studies of injection monoclonal antibody jqknews Post date May 8, 2022 — 15:50 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More